Galectin-3 binding protein promotes cell motility in colon cancer by stimulating the shedding of protein tyrosine phosphatase kappa by proprotein convertase 5

Biochemical and Biophysical Research Communications

Volumn 404, Issue 1, 2011, Pages 96-102

  Kim, Yong Sam ^a   Jung, Jee Ae ^a   Kim, Hyun Jung ^a   Ahn, Yeong Hee ^b   Yoo, Jong Shin ^b   Oh, Sejeong ^c   Cho, Changhee ^a,d   Yoo, Hyang Sook ^a   Ko, Jeong Heon ^a  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b Korea Basic Science Institute (KBSI)   (South Korea)

^c The Catholic University of Korea   (South Korea)

^d University of Science and Technology (UST)   (South Korea)

Author keywords

Galectin 3; Galectin 3 binding protein; Proprotein convertase 5; PTP shedding

Indexed keywords

GALECTIN 3; KEXIN; KEXIN TYPE 5; PROPROTEIN CONVERTASE 5; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE KAPPA; SUBTILISIN; UNCLASSIFIED DRUG;

ARTICLE; CELL MOTILITY; CELL STRAIN HT29; CELL SURFACE; COLON CANCER; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING;

CARRIER PROTEINS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; COLONIC NEOPLASMS; GALECTIN 3; GLYCOPROTEINS; HUMANS; PROPROTEIN CONVERTASE 5; PROTEIN STRUCTURE, TERTIARY; RECEPTOR-LIKE PROTEIN TYROSINE PHOSPHATASES, CLASS 2; TUMOR CELLS, CULTURED;

EID: 78650895502     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.11.071     Document Type: Article

References (17)

1. van Kilsdonk J.W., van Kempen L.C., van Muijen G.N., Ruiter D.J., Swart G.W. Soluble adhesion molecules in human cancers: sources and fates. Eur. J. Cell. Biol. 2010, 89:415-427.
2. Pupa S.M., Menard S., Morelli D., Pozzi B., De Palo G., Colnaghi M. The extracellular domain of the c-erbB-2 oncoprotein is released from tumor cells by proteolytic cleavage. Oncogene 1993, 8:2917-2923.
3. Higashiyama S., Iwabuki H., Morimoto C., Hieda M., Inoue H., Matsushita N. Membrane-anchored growth factors, the epidermal growth factor family: beyond receptor ligands. Cancer Sci. 2008, 99:214-220.
4. Mochizuki S., Okada Y. ADAMs in cancer cell proliferation and progression. Cancer Sci. 2007, 98:621-628.
5. Kim Y.-S., Kang H.-Y., Kim J.-Y., Oh S., Kim C.-H., Ryu C.J., Miyoshi E., Taniguchi N., Ko J.H. Identification of target proteins of N-acetylglucosaminyl transferase V in human colon cancer and implications of protein tyrosine phosphatase kappa in enhanced cancer cell migration. Proteomics 2006, 6:1187-1191.
6. Grassadonia A., Tinari N., Iurisci I., Piccolo E., Cumashi A., Innominato P., D'Egidio M., Natoli C., Piantelli M., Iacobelli S. 90K (Mac-2 BP) and galectins in tumor progression and metastasis. Glycoconj. J. 2004, 19:551-556.
7. Ozaki Y., Kontani K., Teramoto K., Fujita T., Tezuka N., Sawai S., Maeda T., Watanabe H., Fujino S., Asai T., Ohkubo I. Involvement of 90K/Mac-2 binding protein in cancer metastases by increased cellular adhesiveness in lung cancer. Oncol. Rep. 2004, 12:1071-1077.
8. Ulmer T.A., Keeler V., André S., Gabius H.J., Loh L., Laferté S. The tumor-associated antigen 90K/Mac-2-binding protein secreted by human colon carcinoma cells enhances extracellular levels of promatrilysin and is a novel substrate of matrix metalloproteinases-2, -7 (matrilysin) and -9: Implications of proteolytic cleavage. Biochim. Biophys. Acta 2010, 1800:336-343.
9. Inohara H., Raz A. Identification of human melanoma cellular and secreted ligands for galectin-3. Biochem. Biophys. Res. Commun. 1994, 201:1366-1375.
10. Kim Y.-S., Hwang S.Y., Kang H.-Y., Sohn H., Oh S., Kim J.Y., Yoo J.S., Kim Y.H., Kim C.-H., Jeon J.H., Lee J.M., Kang H.A., Miyoshi E., Taniguchi N., Yoo H.-S., Ko J.H. Functional proteomics study reveals that N-acetylglucosaminyl-transferase V reinforces the invasive/metastatic potential of colon cancer through aberrant glycosylation on tissue inhibitor of metalloproteinase-1. Mol. Cell. Proteomics 2008, 7:1-14.
11. Campan M., Yoshizumi M., Seidah N.G., Lee M.E., Bianchi C., Haber E. Increased proteolytic processing of protein tyrosine phosphatase mu in confluent vascular endothelial cells: the role of PC5, a member of the subtilisin family. Biochemistry 1996, 35:3797-3802.
12. Stowell S.R., Arthur C.M., Mehta P., Slanina K.A., Blixt O., Leffler H., Smith D.F., Cummings R.D. Galectin-1, -2, and -3 exhibit differential recognition of sialylated glycans and blood group antigens. J. Biol. Chem. 2008, 283:10109-10123.
13. Cismasiu V.B., Denes S.A., Reiländer H., Michel H., Szedlacsek S.E. The MAM (meprin/A5-protein/PTPmu) domain is a homophilic binding site promoting the lateral dimerization of receptor-like protein-tyrosine phosphatase mu. J. Biol. Chem. 2004, 279:26922-26931.
14. Künzli B.M., Berberat P.O., Zhu Z.W., Martignoni M., Kleeff J., Tempia-Caliera A.A., Fukuda M., Zimmermann A., Friess H., Büchler M.W. Influences of the lysosomal associated membrane proteins (Lamp-1, Lamp-2) and Mac-2-binding protein (Mac-2-BP) on the prognosis of pancreatic carcinoma. Cancer 2002, 94:228-239.
15. Ozaki Y., Kontani K., Hanaoka J., Chano T., Teramoto K., Tezuka N., Sawai S., Fujino S., Yoshiki T., Okabe H., Ohkubo I. Expression and immunogenicity of a tumor- associated antigen, 90K/Mac-2 binding protein, in lung carcinoma. Cancer 2002, 95:1954-1962.
16. Park Y.P., Choi S.C., Kim J.H., Song E.Y., Kim J.W., Yoon D.Y., Yeom Y.I., Lim J.S., Kim J.W., Paik S.G., Lee H.G. Up-regulation of Mac-2 binding protein by hTERT in gastric cancer. Int. J. Cancer 2007, 120:813-820.
17. Sasaki T., Brakebusch C., Engel J., Timpl R. Mac-2 binding protein is a cell-adhesive protein of the extracellular matrix which self-assembles into ring-like structures and binds beta1 integrins, collagens and fibronectin. EMBO J. 1998, 17:1606-1613.